Professional Documents
Culture Documents
Kirk Luca AAMD Poster
Kirk Luca AAMD Poster
dosimetry
Kirk Luca, MS, CMD; Justin Roper, PhD, DABR; Jonathan Wolf, MS, CMD, RT(R)(T); Oluwatosin Kayode, MS,
CMD, RT(R)(T); Jeffrey Bradley, MD; William Stokes, MD; Jiahan Zhang, PhD, DABR
METHODS
• One KBP model was created from prior VMAT cases that treated Dosimetric comparison results for the 30 unilateral test cases.
unilateral HN lymph nodes while a second model was created *Denotes a significant result
from VMAT cases with bilateral HN nodal involvement
• Clinically relevant dose metrics were compared between plans • This study demonstrates that tailored, site-specific KBP
generated from matched and mismatched models models lead to small but significant improvements in
Unilateral model target objectives. plan quality and supports the development of distinct
• Paired-sample t-tests were used for statistical analysis, with the KBP models for specific clinical scenarios
threshold for statistical significance set a priori at 0.05
ACKNOWLEDGEMENTS
RESULTS
• The unilateral model was superior for unilateral HN cases while • Supported by Winship Cancer Institute # IRG-21-137-
the bilateral model was superior for bilateral HN cases 07 -IRG from the American Cancer Society